CD8A and metabolic dysfunction-associated steatohepatitis: Of note, several investigators have reported improvement of NASH and restored hepatic insulin sensitivity and reduced fibrosis using experimental models with deletion of CD8+ T cells (Ghazarian et al., 2017; Van Herck et al., 2019).